SCHEMBL6722397

SCHEMBL6722397

CCN(CC)CC.CCOC(=O)C(CCOc1ccccc1)Cc1ccc(OCCOS(C)(=O)=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.45
PPARG P37231 8/20 0.42
PPARA Q07869 7/20 0.42
BCHE P06276 4/20 0.41
ACHE P22303 4/20 0.41
PPARD Q03181 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
TSHR P16473 2/20 0.39
MAPK1 P28482 2/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PTGES O14684 1/20 0.39
ALOX5 P09917 1/20 0.39
EPHX2 P34913 1/20 0.39
MME P08473 1/20 0.38
ACACB O00763 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6718390 0.95 TDP1 (0.49) TDP1PPARGPPARAPPARDL3MBTL1
SCHEMBL6714897 0.83 PPARG (0.50) TDP1PPARGPPARAMAPK1PTGES
SCHEMBL6718057 0.81 TDP1 (0.54) TDP1PPARGPPARAPPARDL3MBTL1
SCHEMBL6718054 0.80 PPARG (0.50) TDP1PPARGPPARAPPARDL3MBTL1
SCHEMBL6717768 0.80 TDP1 (0.53) TDP1PPARGPPARAPPARDL3MBTL1
SCHEMBL6716007 0.79 TDP1 (0.56) TDP1PPARGPPARAPPARDL3MBTL1
SCHEMBL6713072 0.79 PPARG (0.53) TDP1PPARGPPARAPPARDMAPK1
SCHEMBL6617763 0.76 PPARG (0.46) TDP1PPARGPPARAL3MBTL1MAPK1
SCHEMBL6714958 0.72 MEN1 (0.51) TDP1PPARGPPARAPPARDL3MBTL1
SCHEMBL27605408 0.72 TDP1 (0.61) TDP1PPARGPPARAL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 TDP1 4224/4885PPARG 23/4885PPARA 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.